4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-015351
Director acquired 2,852 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krogulski Kenneth Director | 2023-11-01 | Other acquisition 10b5-1 | +280 | $1.85 | $518 | 225,287 | D |
| Krogulski Kenneth Director | 2023-11-02 | Other acquisition 10b5-1 | +280 | $1.97 | $552 | 225,567 | D |
| Krogulski Kenneth Director | 2023-11-03 | Other acquisition 10b5-1 | +280 | $2.06 | $577 | 225,847 | D |
| Krogulski Kenneth Director | 2023-11-06 | Other acquisition 10b5-1 | +280 | $2.03 | $568 | 226,127 | D |
| Krogulski Kenneth Director | 2023-11-07 | Other acquisition 10b5-1 | +96 | $2.01 | $193 | 226,223 | D |
| Krogulski Kenneth Director | 2023-11-08 | Other acquisition 10b5-1 | +280 | $2.00 | $560 | 226,503 | D |
| Krogulski Kenneth Director | 2023-11-09 | Other acquisition 10b5-1 | +280 | $1.82 | $510 | 226,783 | D |
| Krogulski Kenneth Director | 2023-11-10 | Other acquisition 10b5-1 | +280 | $1.77 | $496 | 227,063 | D |
| Krogulski Kenneth Director | 2023-11-13 | Other acquisition 10b5-1 | +236 | $1.75 | $413 | 227,299 | D |
| Krogulski Kenneth Director | 2023-11-14 | Other acquisition 10b5-1 | +280 | $1.73 | $484 | 227,579 | D |
| Krogulski Kenneth Director | 2023-11-15 | Other acquisition 10b5-1 | +280 | $1.78 | $498 | 227,859 | D |
Loading xslF345X05/marketforms-63541.xml…